• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOCOMPATIBLES U.K. LIMITED DC BEAD; EMBOLIC AGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOCOMPATIBLES U.K. LIMITED DC BEAD; EMBOLIC AGENT Back to Search Results
Model Number 100-300
Device Problem Insufficient Information (3190)
Patient Problems Neurological Deficit/Dysfunction (1982); Dysphasia (2195); Numbness (2415); Test Result (2695)
Event Type  Injury  
Event Description
Report from (b)(6) via medical director of a female, (b)(6) year old patient diagnosed with liver metastases from colorectal cancer.Her liver metastases were treated with chemoembolization with irinotecan loaded dc bead (100-300 microns loaded with 100mg irinotecan).No shunting was identified during angiogram.The patient did not have any previous cardiac medical history.No medical history of stroke.During the procedure the patient experienced difficulty to talk and she complained that she could not feel her leg.A brain mri showed an area of devascularisation compatible with her neurological symptoms.Patient was hospitalized after treatment and her symptoms worsened over a 48 hour period.Follow-up with the hospital is ongoing.
 
Manufacturer Narrative
Company comment: dc bead loaded with irinotecan was used in the treatment of this patient.The equivalent product lc bead is available in the usa, however, it is not indicated for use with drugs.Company medical review determined that this patient developed stroke probably in the context of non-target embolization to her brain through non-visible hepatic av shunts.The dc bead ifu documents undesirable reflux or passage of dc bead microspheres into normal arteries adjacent to the targeted lesion or through the lesion into other arteries or arterial beds and ischaemic stroke or ischaemic infarction as potential complications of product use.This is therefore an anticipated complication.Investigation into this complaint is ongoing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DC BEAD
Type of Device
EMBOLIC AGENT
Manufacturer (Section D)
BIOCOMPATIBLES U.K. LIMITED
farnham business park
weydon ln
farnham, surrey GU9 8QL
UK  GU9 8QL
Manufacturer Contact
farnham business park
weydon lane
farnham, surrey GU9 8-QL
252732732
MDR Report Key3600376
MDR Text Key4068002
Report Number3002124545-2013-00012
Device Sequence Number1
Product Code HCG
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K094018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial
Report Date 11/28/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/01/2016
Device Model Number100-300
Device Catalogue NumberDC2V103
Device Lot NumberV10462
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/15/2013
Initial Date FDA Received01/30/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
DC BEAD WAS LOADED WITH IRINOTECAN PRIOR TO USE
Patient Outcome(s) Life Threatening;
Patient Age73 YR
-
-